Search research articles
Contact Us
Filters
Showing results (131-140 of 152) with videos related to
Page
of 16
Sort By:
Pathology
|
February 27, 2024
The frequency and clinical outcome of mono-hit and multi-hit TP53 aberrations in newly diagnosed multiple myeloma
Sreejesh Sreedharanunni, Shelly Singla, Anand Balakrishnan, et al.
Blood Research
|
April 23, 2016
Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
Karthik Bommannan, Man Updesh Singh Sachdeva, Pankaj Malhotra, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 7, 2025
B Lineage Acute Lymphoblastic Leukemia with concurrent <i>IGH</i> and <i>EPOR</i> rearrangements - An Entity with Dismal Outcome
Nupur Pradhan, Prabhjot Kaur, Venus Thakur, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients
Charanpreet Singh, Nishant Jindal, Padma Youron, et al.
European Journal of Haematology
|
May 28, 2019
Genetic basis of unexplained erythrocytosis in Indian patients
Nabhajit Mallik, Prashant Sharma, Jasbir Kaur Hira, et al.
International Journal of Laboratory Hematology
|
August 28, 2020
The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia
Harpreet Virk, Sonia Rana, Alpeshkumar B Kapadia, et al.
Annals of Hematology
|
June 23, 2021
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort
Harpreet Virk, Sonia Rana, Praveen Sharma, et al.
Clinical and Experimental Medicine
|
July 20, 2023
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia
Dikshat Gopal Gupta, Neelam Varma, Sarki Abba Abdulkadir, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 5, 2024
The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with Variant <i>RARA</i> Rearrangements: A Single Center Experience from India
Anjali Gupta, Sreejesh Sreedharanunni, Charanpreet Singh, et al.
Blood Cell Therapy
|
September 10, 2025
Role of Composite Measurable Residual Disease Assessment with PET-CT and flow cytometry in Multiple Myeloma patients undergoing Autologous Transplant
Rudra Narayan Swain, Arihant Jain, Sarthak Wadhera, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 152) with videos related to
Sort By:
Page
of 16
Pathology
|
February 27, 2024
The frequency and clinical outcome of mono-hit and multi-hit TP53 aberrations in newly diagnosed multiple myeloma
Sreejesh Sreedharanunni, Shelly Singla, Anand Balakrishnan, et al.
Blood Research
|
April 23, 2016
Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
Karthik Bommannan, Man Updesh Singh Sachdeva, Pankaj Malhotra, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 7, 2025
B Lineage Acute Lymphoblastic Leukemia with concurrent <i>IGH</i> and <i>EPOR</i> rearrangements - An Entity with Dismal Outcome
Nupur Pradhan, Prabhjot Kaur, Venus Thakur, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients
Charanpreet Singh, Nishant Jindal, Padma Youron, et al.
European Journal of Haematology
|
May 28, 2019
Genetic basis of unexplained erythrocytosis in Indian patients
Nabhajit Mallik, Prashant Sharma, Jasbir Kaur Hira, et al.
International Journal of Laboratory Hematology
|
August 28, 2020
The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia
Harpreet Virk, Sonia Rana, Alpeshkumar B Kapadia, et al.
Annals of Hematology
|
June 23, 2021
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort
Harpreet Virk, Sonia Rana, Praveen Sharma, et al.
Clinical and Experimental Medicine
|
July 20, 2023
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia
Dikshat Gopal Gupta, Neelam Varma, Sarki Abba Abdulkadir, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
February 5, 2024
The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with Variant <i>RARA</i> Rearrangements: A Single Center Experience from India
Anjali Gupta, Sreejesh Sreedharanunni, Charanpreet Singh, et al.
Blood Cell Therapy
|
September 10, 2025
Role of Composite Measurable Residual Disease Assessment with PET-CT and flow cytometry in Multiple Myeloma patients undergoing Autologous Transplant
Rudra Narayan Swain, Arihant Jain, Sarthak Wadhera, et al.
Page
of 16